ambroxol has been researched along with Respiration Disorders in 3 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a randomized trial in 102 preterm newborns with respiratory distress syndrome (RDS) it has been shown that early Ambroxol treatment (30 mg kg(-1) over the first 5 days) significantly reduces the incidence of RDS-associated complications [bronchopulmonary dysplasia (BPD), intraventricular haemorrhage, post-natal acquired pneumonia]." | 9.09 | Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD). ( Böhme, B; Schmalisch, G; Wauer, RR, 2000) |
| "In a randomized trial in 102 preterm newborns with respiratory distress syndrome (RDS) it has been shown that early Ambroxol treatment (30 mg kg(-1) over the first 5 days) significantly reduces the incidence of RDS-associated complications [bronchopulmonary dysplasia (BPD), intraventricular haemorrhage, post-natal acquired pneumonia]." | 5.09 | Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD). ( Böhme, B; Schmalisch, G; Wauer, RR, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, W | 1 |
| Zhu, D | 1 |
| Wu, F | 1 |
| Xu, JF | 1 |
| Yang, JP | 1 |
| Deng, ZP | 1 |
| Chen, XB | 1 |
| Papi, A | 1 |
| Qu, JM | 1 |
| Schmalisch, G | 1 |
| Wauer, RR | 1 |
| Böhme, B | 1 |
| Bomba-Opoń, DA | 1 |
| Wiczyńska-Zajac, A | 1 |
| Domańska-Janczewska, E | 1 |
| Kociszewska-Najman, B | 1 |
| Marianowski, L | 1 |
2 trials available for ambroxol and Respiration Disorders
| Article | Year |
|---|---|
Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion.
Topics: Acetylcysteine; Ambroxol; Double-Blind Method; Expectorants; Humans; Mucus; Respiration Disorders | 2023 |
Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD).
Topics: Ambroxol; Bronchopulmonary Dysplasia; Double-Blind Method; Expectorants; Female; Humans; Infant, New | 2000 |
1 other study available for ambroxol and Respiration Disorders
| Article | Year |
|---|---|
[The effectiveness of prenatal steroid and ambroxol therapy for the prevention of respiratory distress syndrome in newborns of diabetic mothers].
Topics: Adult; Ambroxol; Anti-Inflammatory Agents; Diabetes Mellitus, Type 1; Expectorants; Female; Humans; | 2000 |